Use of adenosine A3 receptor agonists for treatment of neuropathic pain
US9132131B2 · kind B2 · utility
10Cited by
1References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 14, 2012 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | Aug 24, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating neuropathic pain in a subject is provided. The method comprises administering to a subject a pharmaceutical composition comprising a therapeutically effective amount of an A3AR agonist, optionally further including administering an analgesic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.